Sustained Release Biodegradable Intracanalicular Inserts Comprising a Hydrogel and an Active Agent
Copyright © Targeted News Service 2024
2024-12-10
ALEXANDRIA, Virginia, Dec. 10 -- OCULAR THERAPEUTIX, INC., Bedford, Massachusetts has been assigned a patent (No. US 12161753 B2, initially filed Sept. 23, 2021) developed by five inventors Charles D. Blizzard, Nashua, New Hampshire; Rami El-Hayek, Norwood, Massachusetts; Michael Goldstein, Cambridge, Massachusetts; Peter Jarrett, Burlington, Massachusetts; and Andrew Vanslette, Bolton, Massachusetts, for "Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an act . . .